Table 1.
Correlation between ACSS3 expression and clinicopathological characteristics of bladder cancer patients.
Parameters | Total | ACSS3 expression | P-value | |
---|---|---|---|---|
Low (n = 30) | High (n = 30) | |||
Gender | 0.194 | |||
Male | 33 | 14 | 19 | |
Female | 27 | 16 | 11 | |
Age (years) | 0.519 | |||
<59 | 12 | 7 | 5 | |
≥59 | 48 | 23 | 25 | |
Tumor stage | 0.793 | |||
Ta,T1 | 11 | 5 | 6 | |
T2–T4 | 49 | 25 | 24 | |
TNM stage | 0.010* | |||
S-I | 28 | 19 | 9 | |
S-II + III | 32 | 11 | 21 | |
Grade | 0.004* | |||
G1 | 33 | 22 | 11 | |
G2–G3 | 27 | 8 | 19 | |
Tumor size | 0.781 | |||
<3 cm | 19 | 9 | 10 | |
≥3 cm | 41 | 21 | 20 | |
Lymph node metastasis | 0.000* | |||
Absent | 32 | 9 | 23 | |
Present | 28 | 21 | 7 | |
Distant metastasis | 0.028* | |||
Absent | 48 | 21 | 27 | |
Present | 12 | 9 | 3 |